Although multiple drugs have been applied in the clinical treatment of IBD, such as 5-Aminosalicylates (5-ASAs), corticosteroids, immunosuppressive drugs, and biological agents (e.g., anti-tumor necrosis factor (TNF) agents), there are no curative therapies for IBD (Torres et al., 2020). Here, TNF is linked to inflammatory bowel disease.